"It is our decision to continue the rollout of vaccinations in Denmark without AstraZeneca," said Brostrøm, who added that the case of a 60-year-old Danish woman who died after being vaccinated with AstraZeneca was "very tragic." Earlier in the month, the EMA concluded that the benefits of using the AstraZeneca COVID-19 vaccine continue to outweigh the risks. The Danish Health Authority says it agrees with the agency's general findings and that the possible benefits of AstraZeneca in combating the COVID-19 pandemic continue to outweigh the risk of serious adverse events.